Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Unicycive Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for UNCY.
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM) and Gain Therapeutics (NASDAQ:GANX).
Unicycive Therapeutics has a consensus price target of $6.07.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.6532 last updated May 2, 2025 at 7:33 AM EDT.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q1 earnings are confirmed for Friday, May 16, 2025.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.